blogs

The Million Dollar Question

The Million Dollar Question
A more comprehensive approach to the assessment and reporting of all hospital-onset bacteremia was a major topic at this year's Association for Vascular Access Scientific Meeting. We learned from Michelle DeVries, MPH, CIC, VA-BC lecture "Beyond CLABSI; Considering Hospital Onset Bacteremia," that current literature supports moving beyond just...
Continue reading
  256 Hits
Tags:
catheter PIV peripheralcatheter peripheralintravenouscatheter sepsis
LinkedIn
256 Hits

SKYDANCE VASCULAR SUCCESSFULLY CLOSES INITIAL SEED ROUND

Main-Logo
Innovative startup reshaping the Peripheral Intravenous Catheter (PIV) market closes seed financing round of $2.5M. DELRAY BEACH, Florida (October 27, 2020) – SkyDance Vascular (SkyDance) today announced the completion of their initial seed funding round, securing $2.5M through private investments. The startup, founded in 2017, has reimagined the P...
Continue reading
  502 Hits
Tags:
catheter iv-lines vascularaccess vascular peripheralintravenouscatheter
LinkedIn
502 Hits

SkyDance Vascular Launches New Website In Support of Fund Raising Efforts

Innovative startup reshaping the Peripheral Intravenous Catheter (PIV) market lays out current challenges and groundbreaking solution to a critical healthcare procedure. SkyDance Vascular (SkyDance), a company established to transform the market for Peripheral Intravenous Catheters (PIV), today announces the debut of a new website, www.sk...
Continue reading
  276 Hits
Tags:
catheter vascularaccess vascular medicaldevices PIV
LinkedIn
276 Hits

logo

Company

Contact Us

1104 Nassau Street
Suite 107
Delray Beach, FL 33483

630 Komas Drive
Suite 204
Salt Lake City, UT  84108

Phone: 754.600.1298

www.skydancevascular.com

Osprey reversed

Copyright © , SkyDance Vascular, Inc.

Website designed by Thasis LLC. Technical development by FDI Creative.

This product is not for sale. Commercial availability expected in 2021 following FDA 510(k) clearance.

No statement on this site has been evaluated by the FDA. At the current time, and until 510(k) clearance is obtained from the FDA, all expressed claims made and/or indicated are exclusively the belief of SkyDance Vascular, Inc. The Company intends to proceed with obtaining FDA 510(k) clearance to support what it believes to be appropriate claims, but until such time as FDA 510(k) clearance is achieved all information on this site, and other Company documents are for informational purposes only.